Follow-up of premalignant lesions in patients at risk for progression to gastric cancer

Endoscopy

Volumn 45, Issue 4, 2013, Pages 249-256

  Den Hoed, C M ^a   Holster, I L ^a   Capelle, L G ^a   De Vries, A C ^a   Den Hartog, B ^b   Ter Borg, F ^c   Biermann, K ^a   Kuipers, E J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c DEVENTER HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH BIOPSY; STOMACH CANCER; STOMACH LESION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARDIA; DISEASE PROGRESSION; FEMALE; GASTRITIS, ATROPHIC; GASTROSCOPY; HUMANS; MALE; METAPLASIA; MIDDLE AGED; OBSERVER VARIATION; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; PYLORIC ANTRUM; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STOMACH; STOMACH NEOPLASMS;

EID: 84875324616     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0032-1326379     Document Type: Article

References (33)

1. Karim-Kos H. E., de Vries E., Soerjomataram I. et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer: 2008; 44 1345 1389
2. de Vries A. C., van Grieken N. C., Looman C. W. et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology: 2008; 134 945 952 (Pubitemid 351451990)
3. Gotoda T. Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol: 2006; 22 561 569 (Pubitemid 44197533)
4. Whiting J. L., Sigurdsson A., Rowlands D. C. et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut: 2002; 50 378 381 (Pubitemid 34161055)
5. Dinis-Ribeiro M., Areia M., de Vries A. C. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy: 2012; 44 74 94
6. Lee C. W., Rickman B., Rogers A. B. et al. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res: 2008; 68 3540 3548
7. Mera R., Fontham E. T., Bravo L. E. et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut: 2005; 54 1536 1540 (Pubitemid 41531767)
8. You W. C., Brown L. M., Zhang L. et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst: 2006; 98 974 983 (Pubitemid 44288162)
9. Correa P., Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology: 2007; 133 659 672 (Pubitemid 47187360)
10. El-Zimaity H. M. Gastric atrophy, diagnosing and staging. World J Gastroenterol: 2006; 12 5757 5762 (Pubitemid 44594240)
11. El-Zimaity H. M., Graham D. Y. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Human pathology: 1999; 30 72 77 (Pubitemid 29037397)
12. Farinati F., Cardin R., Cassaro M. et al. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev: 2008; 17 195 200 (Pubitemid 351549658)
13. Motta C. R., Cunha M. P., Queiroz D. M. et al. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from northeastern Brazil. Digestion: 2008; 78 3 8
14. Xia H. H., Kalantar J. S., Talley N. J. et al. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol: 2000; 95 114 121 (Pubitemid 30041544)
15. Eidt S., Stolte M. Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol: 1994; 29 607 610 (Pubitemid 24203063)
16. Meining A. RB, Stolte M. Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol: 2002; 55 770 773 (Pubitemid 35231910)
17. Schultze V., Hackelsberger A., Gunther T. et al. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scand J Gastroenterol: 1998; 33 137 142 (Pubitemid 28098227)
18. Sakitani K., Hirata Y., Watabe H. et al. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol: 2011; 26 1570 1575
19. Kuipers E. J., Uyterlinde A. M., Pena A. S. et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet: 1995; 345 1525 1528
20. Cassaro M., Rugge M., Gutierrez O. et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol: 2000; 95 1431 1438 (Pubitemid 30396299)
21. Tava F., Luinetti O., Ghigna M. R. et al. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasiao" lesions as predictors of gastric neoplasia. Hum Pathol: 2006; 37 1489 1497 (Pubitemid 44584329)
22. Mastracci L., Bruno S., Spaggiari P. et al. The impact of biopsy number and site on the accuracy of intestinal metaplasia detection in the stomach: A morphometric study based on virtual biopsies. Dig Liver Dis: 2008; 40 632 640
23. Rugge M., Correa P., Dixon M. F. et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol: 2000; 24 167 176 (Pubitemid 30078704)
24. Capelle L. G., de Vries A. C., Haringsma J. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc: 2010; 71 1150 1158
25. Dixon M. F., Genta R. M. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol: 1996; 20 1161 1181
26. Dixon M. F. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut: 2002; 51 130 131 (Pubitemid 34717758)
27. Genta R. M., Graham D. Y. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc: 1994; 40 342 345 (Pubitemid 24163073)
28. Rugge M., Correa P., Di Mario F. et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis: 2008; 40 650 658
29. de Vries A. C HJ, de Vries R. A., ter Borg F. et al. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc: 2009; 70 18 25
30. Fleiss J. Statistical methods for rates and proportions. 2nd. edition New York Wiley: 1981
31. de Vries A. C., Meijer G. A., Looman C. W. et al. Epidemiological trends of premalignant gastric lesions: a long term nationwide study in the Netherlands. Gut: 2007; 56 1665 1670 (Pubitemid 350206290)
32. den Hoed C. M., van Eijck B. C., Capelle L. G. et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer: 2011; 47 1211 1218
33. den Hoed C. M., Vila A. J., Holster I. L. et al. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter: 2011; 16 405 409